Treatment Failure Versus Failed Treatments: The Risks of Embracing Treatment Refractory Addiction

Abstract

Abstract In this issue, Strain advocates for the field of addiction medicine to consider a new diagnostic signal—treatment-refractory addiction. Also in this issue, Nunes and McLellan support the concepts advanced by Strain. I provide an alternate view and propose that it is premature to create such a signal and that doing so could lead to unintended adverse consequences. My argument is based on 4 concerns: (1) the lack of neuroscientific correlates, (2) the profound impact that context has on what patients receive as “treatment,” (3) the rare provision of sequentially stepped treatment, and (4) the potential for misuse of the signal. Addiction medicine should be cautious in introducing concepts such as treatment-refractory addiction to ensure that patients are not seen as “treatment failures.” Our efforts should rather focus on the development of additional effective treatments, improving access to existing effective treatments and a creating a system that does not provide “failed treatments.”